133 related articles for article (PubMed ID: 30043652)
1. Functional paclitaxel plus honokiol micelles destroying tumour metastasis in treatment of non-small-cell lung cancer.
Wang X; Cheng L; Xie HJ; Ju RJ; Xiao Y; Fu M; Liu JJ; Li XT
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):1154-1169. PubMed ID: 30043652
[TBL] [Abstract][Full Text] [Related]
2. Inhibiting tumour metastasis by DQA modified paclitaxel plus ligustrazine micelles in treatment of non-small-cell lung cancer.
Xie HJ; Zhao J; Zhuo-Ma D; Zhan-Dui N; Er-Bu A; Tsering T
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3465-3477. PubMed ID: 31432702
[TBL] [Abstract][Full Text] [Related]
3. Development of R
Liu JJ; Tang W; Fu M; Gong XQ; Kong L; Yao XM; Jing M; Cai FY; Li XT; Ju RJ
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1947-1960. PubMed ID: 31079495
[TBL] [Abstract][Full Text] [Related]
4. PTD modified paclitaxel anti-resistant liposomes for treatment of drug-resistant non-small cell lung cancer.
Ju RJ; Cheng L; Xiao Y; Wang X; Li CQ; Peng XM; Li XT
J Liposome Res; 2018 Sep; 28(3):236-248. PubMed ID: 28480778
[TBL] [Abstract][Full Text] [Related]
5. Synergistic killing effect of paclitaxel and honokiol in non-small cell lung cancer cells through paraptosis induction.
Li XQ; Ren J; Wang Y; Su JY; Zhu YM; Chen CG; Long WG; Jiang Q; Li J
Cell Oncol (Dordr); 2021 Feb; 44(1):135-150. PubMed ID: 32936421
[TBL] [Abstract][Full Text] [Related]
6. Antitumor efficacy of Lf modified daunorubicin plus honokiol liposomes in treatment of brain glioma.
Liu S; Zhang SM; Ju RJ; Xiao Y; Wang X; Song XL; Gu LY; Cheng L; Li XT; Chen GR
Eur J Pharm Sci; 2017 Aug; 106():185-197. PubMed ID: 28583810
[TBL] [Abstract][Full Text] [Related]
7. Concurrently suppressing multidrug resistance and metastasis of breast cancer by co-delivery of paclitaxel and honokiol with pH-sensitive polymeric micelles.
Wang Z; Li X; Wang D; Zou Y; Qu X; He C; Deng Y; Jin Y; Zhou Y; Zhou Y; Liu Y
Acta Biomater; 2017 Oct; 62():144-156. PubMed ID: 28842335
[TBL] [Abstract][Full Text] [Related]
8. Biodegradable polymeric micelles coencapsulating paclitaxel and honokiol: a strategy for breast cancer therapy in vitro and in vivo.
Wang N; Wang Z; Nie S; Song L; He T; Yang S; Yang X; Yi C; Wu Q; Gong C
Int J Nanomedicine; 2017; 12():1499-1514. PubMed ID: 28260895
[TBL] [Abstract][Full Text] [Related]
9. Development and characterization of octreotide-modified curcumin plus docetaxel micelles for potential treatment of non-small-cell lung cancer.
An Q; Shi CX; Guo H; Xie SM; Yang YY; Liu YN; Liu ZH; Zhou CZ; Niu FJ
Pharm Dev Technol; 2019 Nov; 24(9):1164-1174. PubMed ID: 31340709
[TBL] [Abstract][Full Text] [Related]
10. Multifunctional liposomes loaded with paclitaxel and artemether for treatment of invasive brain glioma.
Li XY; Zhao Y; Sun MG; Shi JF; Ju RJ; Zhang CX; Li XT; Zhao WY; Mu LM; Zeng F; Lou JN; Lu WL
Biomaterials; 2014 Jul; 35(21):5591-604. PubMed ID: 24726749
[TBL] [Abstract][Full Text] [Related]
11. Application of multifunctional targeting epirubicin liposomes in the treatment of non-small-cell lung cancer.
Song XL; Ju RJ; Xiao Y; Wang X; Liu S; Fu M; Liu JJ; Gu LY; Li XT; Cheng L
Int J Nanomedicine; 2017; 12():7433-7451. PubMed ID: 29066893
[TBL] [Abstract][Full Text] [Related]
12. Discovery and synthesis of novel magnolol derivatives with potent anticancer activity in non-small cell lung cancer.
Tang H; Zhang Y; Li D; Fu S; Tang M; Wan L; Chen K; Liu Z; Xue L; Peng A; Ye H; Chen L
Eur J Med Chem; 2018 Aug; 156():190-205. PubMed ID: 30006164
[TBL] [Abstract][Full Text] [Related]
13. Honokiol enhances paclitaxel efficacy in multi-drug resistant human cancer model through the induction of apoptosis.
Wang X; Beitler JJ; Wang H; Lee MJ; Huang W; Koenig L; Nannapaneni S; Amin AR; Bonner M; Shin HJ; Chen ZG; Arbiser JL; Shin DM
PLoS One; 2014; 9(2):e86369. PubMed ID: 24586249
[TBL] [Abstract][Full Text] [Related]
14. Liposomal honokiol induced lysosomal degradation of Hsp90 client proteins and protective autophagy in both gefitinib-sensitive and gefitinib-resistant NSCLC cells.
Yang J; Wu W; Wen J; Ye H; Luo H; Bai P; Tang M; Wang F; Zheng L; Yang S; Li W; Peng A; Yang L; Wan L; Chen L
Biomaterials; 2017 Oct; 141():188-198. PubMed ID: 28689115
[TBL] [Abstract][Full Text] [Related]
15. The enhanced treatment efficacy of invasive brain glioma by dual-targeted artemether plus paclitaxel micelles.
Li X; Shi L; Li Y; Li Q; Duan X; Wang Y; Li Q
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):983-996. PubMed ID: 32524852
[TBL] [Abstract][Full Text] [Related]
16. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
[TBL] [Abstract][Full Text] [Related]
17. Formylated honokiol analogs showed antitumor activity against lung carcinoma.
Deng S; Zhang C; Yang L; Ma L
Anticancer Drugs; 2019 Sep; 30(8):795-802. PubMed ID: 30807551
[TBL] [Abstract][Full Text] [Related]
18. Synergistic antitumor effects of liposomal honokiol combined with adriamycin in breast cancer models.
Hou W; Chen L; Yang G; Zhou H; Jiang Q; Zhong Z; Hu J; Chen X; Wang X; Yuan Y; Tang M; Wen J; Wei Y
Phytother Res; 2008 Aug; 22(8):1125-32. PubMed ID: 18570244
[TBL] [Abstract][Full Text] [Related]
19. Honokiol nanomicellar formulation produced increased oral bioavailability and anticancer effects in triple negative breast cancer (TNBC).
Godugu C; Doddapaneni R; Singh M
Colloids Surf B Biointerfaces; 2017 May; 153():208-219. PubMed ID: 28249200
[TBL] [Abstract][Full Text] [Related]
20. Systemic delivery of micelles loading with paclitaxel using N-succinyl-palmitoyl-chitosan decorated with cRGDyK peptide to inhibit non-small-cell lung cancer.
Yuan ZQ; Li JZ; Liu Y; Chen WL; Yang SD; Zhang CG; Zhu WJ; Zhou XF; Liu C; Zhang XN
Int J Pharm; 2015 Aug; 492(1-2):141-51. PubMed ID: 26188316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]